# Emergent Medical Partners

Emergent Medical Partners is a Venture Capital based in San Jose, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** San Jose, United States
- **Region:** North America
- **Address:** San Jose, CA, United States
- **Founded:** 2006
- **Assets under management:** Undisclosed
- **Website:** www.emvllp.com
- **LinkedIn:** linkedin.com/company/emergent-medical-partners-lp

## Regulatory record

- **Reports private funds:** No

## About

Emergent Medical Partners provides early-stage life science entrepreneurs with funding and expertise in the financial, medical, and engineering facets of the medical device development process. The firm's team has over 50 years of investment experience and extensive clinical, operational, legal, and financial knowledge to support portfolio companies through the regulatory process.

## Sectors

- Medical Devices
- Life Sciences

## People

- Thomas J. Fogarty — Founder and General Partner
- Robert Brownell — General Partner
- Kirt Kirtland — General Partner
- Kathy Tellyer — Controller and Administrator

## Questions

### Who runs investment decisions at Emergent Medical Partners?

Investment decisions are led by founder and general partner Dr. Thomas J. Fogarty, working alongside general partners Robert Brownell and Kirt Kirtland. Dr. Fogarty brings more than 125 patents and decades of medtech operating experience, while Brownell contributes legal and deal-structuring expertise from his time at Wilson Sonsini and MedVenture Associates. Kirtland adds CEO-level operational experience across multiple device specialties. The firm describes its partnership as highly integrated, with all three general partners involved in sourcing and evaluating deals.

### How does Emergent Medical Partners source proprietary deal flow?

The firm sources opportunities through Dr. Fogarty’s network of clinicians, engineers, and entrepreneurs built over five decades in cardiovascular surgery and medical device invention. The general partners’ combined operating and legal backgrounds provide access to companies at the earliest stages, often before they are visible to larger institutional investors. The firm’s website highlights its ability to identify promising technologies and management teams from its own clinical and industry relationships.

### Does Emergent Medical Partners participate in fund commitments or only direct deals?

The firm focuses on direct, early-stage equity investments in medical device companies. There is no public evidence of fund-of-funds commitments or investments as a limited partner in other venture funds. Its portfolio, as listed on the firm’s website, consists entirely of names of directly held operating companies across multiple device sectors.

### Which sectors does Emergent Medical Partners explicitly avoid?

The firm’s portfolio and team bios show a clear concentration on medical devices, with no investments in pharmaceuticals, biotechnology platforms, healthcare services, or healthcare IT outside of device-enabling software. Companies like Arterys represent a software component, but the firm does not list any pure digital health or therapeutics plays outside device-drug combinations like the Incline Therapeutics acquisition.

## Related profiles

- [Emergent Asset Management](https://altss.com/profile/emergent-asset-management)
- [Emergent Technologies](https://altss.com/profile/emergent-technologies)

---

Last updated: 2026-07-10T22:58:29.000Z

Canonical page: https://altss.com/profile/emergent-medical-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology